Abstract
Oxygen free radical formation has been implicated in lesions caused by the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and iron. Although MPTP produces a parkinsonian syndrome after its conversion to 1-methyl-4-phenylpyridine (MPP+) by type B monoamine oxidase (MAO) in the brain, the etiology of this disease remains obscure. This review focuses on the role of an environmental neurotoxin chemically related to MPP+-induced free radical generation in the pathogenesis of Parkinson's disease. Environmental-like chemicals, such as para-nonylphenol or bisphenol A, significantly stimulated hydroxyl radical (•OH) formation in the striatum. Allopurinol, a xanthine oxidase inhibitor, prevents para-nonylphenol and MPP+-induced •OH generation. Tamoxifen, a synthetic nonsteroidal antiestrogen, suppressed the •OH generation via dopamine efflux induced by MPP+. These results confirm that free radical production might make a major contribution at certain stages in the progression of the injury. Such findings may be useful in elucidating the actual mechanism of free radical formation in the pathogenesis of neurodegenerative brain disorders, including Parkinson's disease and traumatic brain injuries.
Similar content being viewed by others
REFERENCES
Colborn, T. 1995. Environmental oestrogen: health implications for humans and wildlife. Environ. Health Persp. 103:135–136.
Safe, S. H. 1995. Do environmental estrogens play a role in development of breast cancer in women and male reproductive problems? Hum. Ecol. Risk Assess. 1:17–23.
Kuppers, E. and Beyer, C. 1999. Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum. Neurosci. Lett. 276:95–98.
Lammers, C. H., D'Souza, U., Qin, Z. H., Lee, S. H., Yajima, S., and Mouradian, M. M. 1999. Regulation of striatal dopamine receptors by estrogen. Synapse 34:222–227.
Zhou, Y. and Dorsa, D. M. 1994. Estrogen rapidly induces c-jun immunoreactivity in rat striatum. Horm. Behav. 28:376–382.
Mizuno, Y., Hattori, N., and Mori, H. 1999. Genetics of Parkinson's disease. Biomed. Pharmacother. 53:109–116.
Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. 1996. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137:120–123.
Chiueh, C. C., Wu, R.-M., Mohanakumar, K. P., Sternberger, L. M., Krishna, G., Obata, T., and Murphy, D. L. 1994. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. NY Acad. Sci. 738:25–36.
Gerlach, M., Ben-Shachar, D., Riederer, P., and Youdim, M. B. H. 1994. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:793–807.
Chiba, K., Trevor, A., and Castagnoli, N. 1984. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120:574–578.
Markey, S. P., Johannessen, J. N., Chiueh, C. C., Burns, R. S., and Herkenham, M. A. 1984. Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism. Nature 311:464–467.
Kopin, I. J. and Markey, S. P. 1988. MPTP toxicity: implications for research in Parkinson's disease. Annu. Rev. Neurosci. 11:81–96.
Dunnett, S. B. and Bjorklund, A. 1999. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399:A32–39.
Olanow, C. W. and Tatton, W. G. 1999. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22:123–144.
Chiueh, C. C., Krishna, G., Tulsi, P., Obata, T., Lang, K., Huang, S.-J., and Murphy, D. L. 1992. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP1. Free Radic. Biol. Med. 13:581–583.
Kitamura, Y., Shimohama, S., Akaike, A., and Taniguchi, T. 2000. The parkinsonian models: invertebrates to mammals. Jpn. J. Pharmacol. 84:237–243.
Obata, T. 1999. Reserpine prevent hydroxyl radical formation by MPP1 in rat striatum. Brain Res. 828:68–73.
Maher, P. and Davis, J. B. 1996. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:6394–6401.
Tan, S., Wood, M., and Maher, P. 1998. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71: 95–105.
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 2:381–389.
Chiueh, C. C., Miyake, H., and Peng, M. T. 1993. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60:251–258.
Floyd, R. A., Watson, J. J., and Wong, P. K. 1984. Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J. Biochem. Biophys. Meth. 10:221–235.
Radzik, D. M., Roston, D. A., and Kissinger, P. T. 1983. Determination of hydroxylated aromatic compounds produced via superoxide-dependent formation of hydroxyl radicals by liquid chromatography/electrochemistry. Anal. Biochem. 131:458–464.
Cao, W., Carney, J. M., Duchon, A., Floyd, R. A., and Chevion, M. 1988. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci. Lett. 88:233–238.
Powell, S. R. and Hall, D. 1990. Use of salicylate as a probe for •OH formation in isolated ischemic rat hearts. Free Rad. Biol. Med. 9:133–141.
Halliwell, B., Kaur, H., and Ingleman-Sundberg, M. 1991. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Rad. Biol. Med. 10:439–441.
Obata, T. and Chiueh, C. C. 1992. In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+ and MPP+. J. Neural. Transm. [GenSect] 89:139–145.
Miyake, H. and Chiueh, C. C. 1989. Effects of MPP+ on the release of serotonin and 5–hydroxyindole acetic acid from rat striatum in vivo. Eur. J. Pharmacol. 166:49–55.
Ozaki, N., Nakahara, D., Kaneda, N., Kiuchi, K., Okada, T., Kasahara, Y., and Nagatsu, T. 1987. Acute effects of 1–methyl-4–phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique. J. Neural. Transm. 70:241–250.
Rollema, H., Kuhr, W. G., Kranenborg, G., De, Vries, J., and Van den Berg, C. 1988. MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis. J. Pharmacol. Exp. Ther. 245:858–866.
Graham, D. C. 1984. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5:83–96.
Fornstedt, B., Pileblad, E., and Carlsson, A. 1990. In vivo autoxidation of dopamine in guinea pig striatum increases with age. J. Neurochem. 55:655–659.
Ben-Shachar, D., Riederer, P., and Youdim, M. B. H. 1991. Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J. Neurochem. 57:1609–1614.
Fornstedt, B., Burn, A., Rosengren, E., and Carlson, A. 1989. The apparent autooxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural. Tansm. [P-DSect] 1:279–295.
Cass, W. A. 1997. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J. Pharmacol. Exp. Ther. 280:105–113.
Finnegan, K. T. and Taraska, T. 1996. Effects of glutamate antagonists on methamphetamine and 3,4–methylenedioxy-methamphetamine-induced striatal dopamine release in vivo. J. Neurochem. 66:1949–1958.
Obata, T. and Yamanaka, Y. 2000. Methamphetamine enhances 1–methyl-4–phenylpyridinium ion-induced hydroxyl radical generation in the rat striatum. Neurosci. Lett. 292:54–56.
Riederer, P., Sofic, E., Rausch, W.-D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. H. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:515–520.
Dedon, P. C., Plastaras, J. P., Rouzer, C. A., and Marnett, L. J. 1998. Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. Proc. Natl. Acad. Sci. USA 95:11113–11116.
Perry, T. L. and Yong, V. W. 1986. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67:269–274.
Kinemuchi, H., Fowler, C. J., and Tipton, K. F. 1987. The neurotoxicity of 1–methyl-4–phenyl-1,2,3,6–tetrahydropyridine (MPTP) and its relevance to parkinson disease. Neurochem. Int. 11:359–373.
Di Monte, D. A., Royland, J. E., Anderson, A., Castagnoli, K., Castagnoli, Jr. N., and Langston, J. W. 1997. Inhibition of monoamine oxidase contributes to the protective effect of 7–nitroindazole against MPTP neurotoxicity. J. Neurochem. 69:1771–1773.
Mytilineou, C., Leonardi, E. K., Radcliffe, P., Heinonen, E. H., Han, S. K., Werner, P., Cohen, G., and Olanow, C. W. 1998. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J. Pharmacol. Exp. Ther. 284:700–706.
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301–1306.
Spina, M. B. and Cohen, G. J. 1989. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. USA 86:1398–1400.
Pilas, B., Sarna, T., Kalyanaraman, B., and Swartz, H. M. 1988. The effect of melanin on iron associated decomposition of hydrogen peroxide. Free Rad. Biol. Med. 4:285–293.
Roy, D., Palangt, M., Chen, C.-W., Thomas, R. D., Colerangle, J., Atkinson, A., and Yan, Z.-J. 1997. Biochemical and molecular changes at the cellular level in response to exposure to environmental esrogen-like chemicals. J. Toxicol. Environ. Health 50:1–29.
Haupt, D. E. 1983. U.S. Detergent surfactant trends: 1980's. Tenside Detergents 20:332–337.
Obata, T. and Kubota, S. 2000. Formation of hydroxy radicals by environmental estrogen-like chemicals in rat striatum. Neurosci. Lett. 296:41–44.
Roy, D. and Liehr, J. G. 1999. Estrogen, DNA damage and mutations. Mutat. Res. 424:107–115.
Hirsch, E. C., Brandel, J.-P., Galle, P., Javoy-Agid, F., and Agid, Y. 1991. Iron (II) and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56:446–451.
Obata, T., Kubota, S., and Yamanaka, Y. 2001. Allopurinol suppresses para-nonylphenol and 1–methyl-4–phenylpyridinium ion-induced hydroxyl radical generation in rat striatum. Neurosci. Lett. 306:9–12.
Birge, S. J. 1997. The role of estrogen in the treatment of Alzheimer's disease. Neurology 48:S36–41.
Tang, M. X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeux, R. 1996. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429–432.
Arvin, M., Fedorkova, L., Disshon, K. A., Dluzen, D. E., and Leipheimer, R. E. 2000. Estrogen modulates responses of striatal dopamine neurons to MPP (1): evaluations using in vitro and in vivo techniques. Brain Res. 872:160–171.
Kedar, R. P., Bourne, T. H., Collins, W. P., Ashley, S. E., Cosgrove, D. O., and Campbell, S. 1994. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318–1321.
Thangaraju, M., Vijaylakshmi, T., and Sachdanandam, P. 1994. Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer 74:78–82.
Wiseman, H., Cannon, M., Arnstein, H. R. V., and Halliwell, B. 1993. Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen. Biochim. Biophys. Acta 1181:201–206.
Renodon, A., Boucher, J. L., Sari, M. A., Delaforge, M., Quazzani, J., and Mansuy, D. 1997. Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen. Biochem. Pharmacol. 54:1109–1114.
Wiseman, H., Cannon, M., Arnstein, H. R. V., and Barlow, D. J. 1992. The structural mimicry of membrane sterols by tamoxifen: evidence from cholesterol coefficients and molecular-modelling for its action as a membrane anti-oxidant and an anti-cancer agent. Biochim. Biophys. Acta 1138:197–202.
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620–1624.
Obata, T. and Yamanaka, Y. 2001. Nitric oxide enhances MPP1–induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum. Brain Res. 902:223–228.
Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481–487.
Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., and Beal, M. F. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1017–1021.
Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V. L., and Dawson, T. M. 1996. Role of neuronal nitric oxide in 1–methyl-4–phenyl-1,2,3,6–tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93:4565–4571.
Matthews, R. T., Yang, L., and Beal, M. F. 1997. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp. Neurol. 143: 282–286.
Osborne, K., Zhao, H., and Fuqua, A. W. 2000. Selective estrogen receptor modulators: structure, function, and clinical use. J. Clin. Oncol. 18:3172–3186.
Obata, T. and Kubota, S. 2001. Protective effect of tamoxifen on 1–methyl-4–phenylpyridine-induced hydroxyl radical generation in the rat striatum. Neurosci. Lett. 308:87–90.
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., and Beal, M. F. 2000. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3–nitropropionic acid, and 1–methyl-4–phenyl-1,2,5,6–tetrahydropyridine. J. Neurosci. 20:1–7.
Poth, M. M., Heath, R. G., and Ward, M. 1975. Angiotensin-converting enzyme in human brain. J. Neurochem. 25:83–85.
Chai, S. Y., Mendelsohn, F. A., and Paxinos, G. 1987. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20:615–627.
Konings, C. H., Kuiper, M. A., Bergmans, P. L., Grijpma, A. M., van Kamp, G. J., and Wolters, E. C. 1994. Increased angiotensin converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease. Clin. Chim. Acta 231:101–106.
Zubenko, G. S., Volicer, L., Direnfeld, L. K., Freeman, M., Langlais, P. J., and Nixon, R. A. 1985. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. Brain Res. 328:215–221.
Brown, D. C., Steward, L. J., Ge, J., and Barnes, N. M. 1996. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Br. J. Pharmacol. 118:414–420.
Jenkins, T. A., Allen, A. M., Chai, S. Y., MacGregor, D. P., Paxinos, G., and Mendelsohn, F. A. 1996. Interactions of angiotensin II with central dopamine. Adv. Exp. Med. Biol. 396:93–103.
Jenkins, T. A., Wong, J. Y., Howells, D. W., Mendelsohn, F. A., and Chai. S. Y. 1999. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse. J. Neurochem. 73:214–219.
Juggi, J. S., Koenig-Berard, E., and Van Gilst, W. H. 1993. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. Can. J. Cardiol. 9:336–352.
Obata, T., Kubota, S., and Yamanaka, Y. 2002. Protective effect of histidine on para-nonylphenol enhanced hydroxyl free radical generation induced by 1–methyl-4–phenylpyridinium ion (MPP+) in rat striatum. Biochim. Biophys. Acta (in press).
Halliwell, B. 1992. Reactive oxygen species and central nervous system. J. Neurochem. 59:1609–1623.
Hearse, D. J., Kusama, Y., and Bernier, M. 1989. Rapid electrophysiological changes leading to arrhythmia in the aerobic rat heart: photosensitivization studies with rose bengal-derived reactive oxygen intermediates. Circ. Res. 65:146–153.
Kalyanaraman, B., Feix, J. B., Sieber, F., Thomas, J. P., and Girotti, A. W. 1987. Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen. Proc. Natl. Acad. Sci. USA 84:2999–3003.
Wefers, H., Schulte-Frohlinde, D., and Sies, H. 1987. Loss of transforming activity of plasmid DNA (pBR322) in E. coli. caused by singlet molecular oxygen. FEBS Lett. 211:49–52.
Kukreja, R. C., Loesser, K. E., Kearns, A. A., Naseem, S. A. and Hess, M. L. 1993. Protective effects of histidine during ischemia-reperfusion in isolated perfused rat hearts. Am. J. Physiol. 264:H1370–1381.
Suzuki, Y. and Sudo, J. 1990. Lipid peroxidation and generations of oxygen radicals induced by cephaloridine in renal cortical microsomes of rats. Jpn. J. Pharmacol. 52:233–243.
Takemura, G., Onodera, T., and Ashraf, M. 1992. Quantification of hydroxyl radical and its lack of relevance to myocardial injury during early reperfusion after graded ischemia in rat hearts. Circ. Res. 71:96–105.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Obata, T. Environmental Estrogen-Like Chemicals and Hydroxyl Radicals Induced by MPTP in the Striatum: A Review. Neurochem Res 27, 423–431 (2002). https://doi.org/10.1023/A:1015556015299
Issue Date:
DOI: https://doi.org/10.1023/A:1015556015299